Head of US Commercial
Gil Rivas is an accomplished healthcare executive with a 30-year track record of bringing new therapies to the market. He has launched over 25 new products globally with experience in both start-up and multinational companies. He was Vice-President Global Marketing for Thoratec Corporation (acquired by St Jude Medical), EVP Commercial Operations at Bacchus Vascular (acquired by Covidien) and has worked for various divisions of Johnson and Johnson. He also began his career in sales with Baxter Healthcare Corporation. Most recently, he was Senior Vice President and General Manager for the Cordis Interventional Business (Cardinal Health). He has an undergraduate degree from the Wharton School, University of Pennsylvania and an MBA from the Kellogg School, Northwestern University.